Jan 12, 2026 9:15am EST Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Jan 5, 2026 9:15am EST Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study